Trial Details
COMPLETEDBasic Information
| Clinical ID | c4552 |
|---|---|
| Identifier | NCT00338650 |
| Trial Title | Treatment of the Human Anti-TNF Monoclonal Antibody Adalimumab in Moderate to Severe Crohn's Disease With Previous Exposure to Infliximab (CHOICE) |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Crohn's Disease |
| Interventions | DRUG: adalimumab |
Participant Information
| Sponsor | Abbott |
|---|---|
| City | Birmingham |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE3 |
Time Information
| Start Date | 2006-06 |
|---|---|
| Primary Completion Date | - |
| Completion Date | 2007-05 |